Leucine-rich α-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus

Acta Neurochirurgica

Volumn 153, Issue 6, 2011, Pages 1339-1346

  Nakajima, Madoka ^a   Miyajima, Masakazu ^a   Ogino, Ikuko ^a   Watanabe, Maki ^a   Miyata, Haruko ^a   Karagiozov, Kostadin L ^a   Arai, Hajime ^a   Hagiwara, Yoshiaki ^a,b   Segawa, Tatsuya ^b   Kobayashi, Kyoko ^b   Hashimoto, Yasuhiro ^c  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Immuno Biological Laboratories Co Ltd   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cerebrospinal fluid; Idiopathic normal pressure hydrocephalus; Leucine rich alpha 2 glycoprotein; Shunt placement; Tau protein

Indexed keywords

ALPHA2 GLYCOPROTEIN; BIOLOGICAL MARKER; LEUCINE RICH ALPHA 2 GLYCOPROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CEREBROSPINAL FLUID SHUNTING; CLINICAL EVALUATION; CONTROLLED STUDY; DEMENTIA; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL ASSESSMENT BATTERY; GAIT DISORDER; HUMAN; IDIOPATHIC DISEASE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NERVE CELL DEGENERATION; NEUROLOGIC EXAMINATION; NORMOTENSIVE HYDROCEPHALUS; OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FUNCTION; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; TAU PROTEINS; VENTRICULOPERITONEAL SHUNT;

EID: 79959546087     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-011-0963-z     Document Type: Article

References (38)

1. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH (1965) Symptomatic occult hydrocephalus with "normal" cerebrospinal-fluid pressure. A treatable syndrome. N Engl J Med 273:117-126
2. Baker K, Rochester L, Nieuwboer A (2007) The immediate effect of attentional, auditory, and a combined cue strategy on gait during single and dual tasks in Parkinson's disease. Arch Phys Med Rehabil 88:1593-1600 (Pubitemid 350151387)
3. Baker K, Rochester L, Nieuwboer A (2008) The effect of cues on gait variability-reducing the attentional cost of walking in people with Parkinson's disease. Parkinsonism Relat Disord 14:314-320
4. Bian H, Van Swieten JC, Leight S, Massimo L, Wood E, Forman M, Moore P, de Koning I, Clark CM, Rosso S, Trojanowski J, Lee VM, Grossman M (2008) CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 70:1827-1835 (Pubitemid 351653951)
5. Burn JP (1992) Reliability of the modified Rankin scale. Stroke 23:438
6. Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a Frontal Assessment Battery at bedside. Neurology 55:1621-1626
7. Ewers M, Buerger K, Teipel SJ, Scheltens P, Schroder J, Zinkowski RP, Bouwman FH, Schonknecht P, Schoonenboom NS, Andreasen N, Wallin A, DeBernardis JF, Kerkman DJ, Heindl B, Blennow K, Hampel H (2007) Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI. Neurology 69:2205-2212 (Pubitemid 350294675)
8. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
9. Graff-Radford NR, Godersky JC (1986) Normal-pressure hydrocephalus. Onset of gait abnormality before dementia predicts good surgical outcome. Arch Neurol 43:940-942
10. Graff-Radford NR, Godersky JC (1989) Symptomatic congenital hydrocephalus in the elderly simulating normal pressure hydrocephalus. Neurology 39:1596-1600 (Pubitemid 20013595)
11. Hakim S, Adams RD (1965) The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 2:307-327
12. Hakim S, Venegas JG, Burton JD (1976) The physics of the cranial cavity, hydrocephalus and normal pressure hydrocephalus: mechanical interpretation and mathematical model. Surg Neurol 5:187-210
13. Hashimoto M, Ishikawa M, Mori E, Kuwana N, Sinphoni Group AF (2010) Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res 7:18
14. Haupt H, Baudner S (1977) Isolation and characterization of an unknown, leucine-rich 3.1-S-alpha2-glycoprotein from human serum (author's transl). Hoppe-Seylers Z Physiol Chem 358:639-646 (Pubitemid 8274041)
15. Iqbal K, Grundke-Iqbal I (2008) Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J Cell Mol Med 12:38-55 (Pubitemid 351436349)
16. Iqbal K, Liu F, Gong CX, Alonso Adel C, Grundke-Iqbal I (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118:53-69
17. Ishikawa M (2004) Clinical guidelines for idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo) 44:222-223
18. Ishikawa M, Hashimoto M, Kuwana N, Mori E, Miyake H, Wachi A, Takeuchi T, Kazui H, Koyama H (2008) Guidelines for management of idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo) 48:S1-S23
19. Kapaki E, Paraskevas GP, Papageorgiou SG, Bonakis A, Kalfakis N, Zalonis I, Vassilopoulos D (2008) Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord 22:47-53 (Pubitemid 351651397)
20. Kapaki EN, Paraskevas GP, Tzerakis NG, Sfagos C, Seretis A, Kararizou E, Vassilopoulos D (2007) Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease. Eur J Neurol 14:168-173 (Pubitemid 46148304)
21. Kudo T, Mima T, Hashimoto R, Nakao K, Morihara T, Tanimukai H, Tsujio I, Koike Y, Tagami S, Mori H, Nakamura Y, Tanaka T, Mori K, Takeda M (2000) Tau protein is a potential biological marker for normal pressure hydrocephalus. Psychiatry Clin Neurosci 54:199-202 (Pubitemid 30253254)
22. Li X, Miyajima M, Jiang C, Arai H (2007) Expression of TGF-betas and TGF-beta type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus. Neurosci Lett 413:141-144 (Pubitemid 46195188)
23. Li X, Miyajima M, Mineki R, Taka H, Murayama K, Arai H (2006) Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics. Acta Neurochir (Wien) 148:859-864, discussion 864
24. Matsushima N, Tanaka T, Enkhbayar P, Mikami T, Taga M, Yamada K, Kuroki Y (2007) Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate Toll-like receptors. BMC Genomics 8:124
25. McGirt MJ, Woodworth G, Coon AL, Thomas G, Williams MA, Rigamonti D (2005) Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus. Neurosurgery 57:699-705, discussion 699-705
26. McGirt MJ, Woodworth G, Coon AL, Thomas G, Williams MA, Rigamonti D (2008) Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus. Neurosurgery 62(Suppl 2):670-677
27. Meier U, Miethke C (2003) Predictors of outcome in patients with normal-pressure hydrocephalus. J Clin Neurosci 10:453-459 (Pubitemid 36876655)
28. Mori K (2001) Management of idiopathic normal-pressure hydrocephalus: a multiinstitutional study conducted in Japan. J Neurosurg 95:970-973
29. Morihara T, Kudo T, Ikura Y, Kashiwagi Y, Miyamae Y, Nakamura Y, Tanaka T, Shinozaki K, Nishikawa T, Takeda M (1998) Increased tau protein level in postmortem cerebrospinal fluid. Psychiatry Clin Neurosci 52:107-110 (Pubitemid 28188988)
30. Nishimura T, Takeda M, Nakamura Y, Yosbida Y, Arai H, Sasaki H, Shouji M, Hirai S, Khise K, Tanaka K, Hamamoto M, Yamamoto H, Matsubayashi T, Urakami K, Adachi Y, Nakashima K, Toji H, Nakamura S, Yoshida H (1998) Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan. Methods Find Exp Clin Pharmacol 20:227-235 (Pubitemid 28255413)
31. O'Donnell LC, Druhan LJ, Avalos BR (2002) Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation. J Leukoc Biol 72:478-485
32. Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, Rosengren L, Vanmechelen E, Blennow K (2005) Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem 51:336-345 (Pubitemid 40175803)
33. Pujari S, Kharkar S, Metellus P, Shuck J, Williams MA, Rigamonti D (2008) Normal pressure hydrocephalus: long-term outcome after shunt surgery. J Neurol Neurosurg Psychiatry 79:1282-1286
34. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362:329-344
35. Sasaki M, Honda S, Yuasa T, Iwamura A, Shibata E, Ohba H (2008) Narrow CSF space at high convexity and high midline areas in idiopathic normal pressure hydrocephalus detected by axial and coronal MRI. Neuroradiology 50:117-122
36. Savolainen S, Hurskainen H, Paljarvi L, Alafuzoff I, Vapalahti M (2002) Five-year outcome of normal pressure hydrocephalus with or without a shunt: predictive value of the clinical signs, neuropsychological evaluation and infusion test. Acta Neurochir (Wien) 144:515-523, discussion 523
37. Shirai R, Hirano F, Ohkura N, Ikeda K, Inoue S (2009) Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response. Biochem Biophys Res Commun 382:776-779
38. Wikkelso C, Andersson H, Blomstrand C, Lindqvist G, Svendsen P (1986) Normal pressure hydrocephalus. Predictive value of the cerebrospinal fluid tap-test. Acta Neurol Scand 73:566-573